Fig. 3From: Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre studyCD4 cell count at follow-up intervals of 6 months in Nevirapine (NVP) and Efavirenz (EFV) groupBack to article page